secwatch.observer — SEC 8-K summary
======================================

Issuer:     KORU Medical Systems, Inc. (KRMD)
CIK:        0000704440
Form:       8-K
Filed at:   2022-05-04T23:59:59+00:00
Accession:  0001161697-22-000215
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

KORU Medical Q1 net sales up 15% to $6.2M, net loss widens to $2.5M, raises FY22 revenue guidance
--------------------------------------------------------------------------------

- Net sales $6.24M (+15% YoY); domestic core up 13.2%, novel therapies $0.36M (including NRE).
- GAAP net loss $2.5M (-$0.06 EPS) vs $1.3M loss (-$0.03 EPS) prior year; adjusted EPS -$0.05.
- Gross margin 58.0% (-150bps) on higher raw material/labor costs; operating expenses $6.7M (+24% YoY).
- Raises FY22 revenue guidance to $26.5-$27.0M (prev $26.0-$27.0M); reaffirms 60% gross margin exit run rate.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/704440/000116169722000215/0001161697-22-000215-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/704440/000116169722000215/form_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001161697-22-000215

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer